Fucoidan Dosage, half-life & reference guide
Also known as Oligo-fucoidan · Low-molecular-weight fucoidan · Brown seaweed extract · Undaria extract
Reviewed Evidence: EmergingPublished by PepVault
A sugar-like compound from brown seaweed, studied for inflammation and immunity. In a small 12-week trial, older adults on a low-molecular-weight fucoidan gained grip strength and walking distance. Other small trials looked at asthma and at side effects during cancer treatment. Overall, the human evidence is thin.
- Studied range
- 1–8 g
- How often
- Daily
- Evidence
- ●
●●Emerging - Routes
- Oral capsule, Oral liquid
Studied in research — not a recommendation.
How it works.
Fucoidan is a sulfated sugar chain from brown seaweeds such as wakame (Undaria). In cell and animal studies it calms inflammation and tunes immune responses. Human trials are few and small: in older adults, 12 weeks of a low-molecular-weight form improved grip strength and walking distance; in asthma it nudged lung function; beside cancer treatment it eased some side effects. A 2026 review of the human studies called its clinical effects unclear.
Commonly reported: Nothing felt.
Your report
Taken Fucoidan? What did you notice?
One tap to start. About 30 seconds, no account.

Week by week.
What to expect in the first 8 weeks
- Onset
- Not established
- Peak effect
- 12 weeks (older-adult trial)
- Duration
- Trials ran about 3 months
Day 1–84RCT
Grip strength in older adults
In a 12-week placebo-controlled trial in adults over 60, a low-molecular-weight fucoidan improved grip strength, beyond a clinically meaningful change in about two-thirds, and walking distance. One small trial, without exercise added.
The science
Chang 2026 (Arch Gerontol Geriatr): 60 adults ≥ 60, oligo-fucoidan, oligo-fucoidan + BCAA + vitamin D, or placebo for 12 weeks; grip strength p < 0.001 (r = 0.82), 64.7% exceeded the MCID; 6-minute walk improved (p < 0.001).
Sources- Chang et al. (2026)
Updated Nov 2026
Day 1–30Clinical
Doses vary tenfold
Fucoidan trials used very different amounts, from 1 g a day to 8 g a day, and different molecular sizes. Products are not interchangeable by weight, which makes the evidence hard to apply.
The science
Tsai 2023 cites an open-label trial of 500 mg twice daily (Undaria-derived, breast cancer) and a trial of 4 g low-molecular-weight fucoidan twice daily (colorectal cancer).
Sources- Tsai et al. (2023)
Updated Nov 2026
Day 28–168RCT
Immune signals in small trials
In people with asthma on regular treatment, fucoidan nudged lung function up and shifted immune-cell profiles. Beside rectal-cancer treatment, fewer people had rash, itching and fatigue. Both trials were small.
The science
Yeh 2022 (Sci Rep): 20 patients with asthma, oligo-fucoidan or placebo; FEV1/FVC up (p = 0.046), WBC down, IFN+ and CD4+IFN+ cells up. Tsai 2023 (Integr Cancer Ther): 87 patients with locally advanced rectal cancer on neoadjuvant chemoradiotherapy, LMF or placebo; physical well-being better at 2–3 months, FACT-C not significant; rash, itching and fatigue less common.
Sources- Yeh et al. (2022)
- Tsai et al. (2023)
Updated Nov 2026
Any dayRCT
What fucoidan is built on
Mostly cell and animal work, plus a few small human trials of branded low-molecular-weight extracts. A 2026 review of the human studies found the clinical effects unclear. It has not been tested for lifespan.
The science
Anari 2026 (Food Funct): 5 human interventional studies (3 RCTs, 2 open-label), no meta-analysis possible. Not tested by the NIA ITP.
Sources- Anari et al. (2026)
Updated Nov 2026
With CreatineCommunity
A muscle stack for older adults, untested
The older-adult trial also had an arm with amino acids and vitamin D. Creatine, the best-proven muscle supplement for older adults, has not been tested with fucoidan.
The science
Chang 2026 included an oligo-fucoidan + BCAA + vitamin D arm. Creatine: its library entry (Chilibeck 2017). Combination: untested.
Sources- Chang et al. (2026)
Updated Nov 2026
Day 1 is the day you start it.
Three small RCTs and a 2026 systematic review; preclinical work dominates.
Preliminary research
A typical run.
Run notes
- Cycle
- Daily for 12 weeks (older adults) to several months (adjunct trials).Community practice — opinions vary. Not a clinical recommendation.
- Timing
- No trial compared times of day.
- Routes
- Oral capsule, Oral liquid
- Stacks
- Creatine, Vitamin D3 + K2, Omega-3 (EPA/DHA)
Safety.
Common side effects
- Usually none reported in the small trials
Interactions
No drug interactions were reported in the trials read. Discuss any prescription medications with your clinician, including cancer treatment.
Safety notes
A dietary supplement from seaweed. The small trials read reported no safety concerns. People with cancer use it only alongside their oncology team's treatment, never instead of it. Discuss with your clinician.
Goes with.
One question at a time.
Questions people ask.
What is Fucoidan?
A sugar-like compound from brown seaweed, studied for inflammation and immunity. In a small 12-week trial, older adults on a low-molecular-weight fucoidan gained grip strength and walking distance. Other small trials looked at asthma and at side effects during cancer treatment. Overall, the human evidence is thin.
How is Fucoidan dosed in research?
The research range for Fucoidan is 1–8 g, daily. Studied in research — not a recommendation.
How long does Fucoidan last?
The half-life of Fucoidan is not established in the sources read.
What do people report on Fucoidan?
Commonly reported on Fucoidan: nothing felt.
Is Fucoidan safe?
The research basis for Fucoidan is emerging: primarily preclinical / limited human data. Common side effects in the library: usually none reported in the small trials.
What does Fucoidan stack with?
Common stacks for Fucoidan: Creatine, Vitamin D3 + K2 and Omega-3 (EPA/DHA).
Research.
Reference.
- Cadence
Daily
- Half-life
Not established in the sources read
- Research basis
●
●●EmergingPrimarily preclinical / limited human data
Reviewed How we check the library
